HCN channels in the heart: lessons from mouse mutants

Area of Science:

• Cardiology
• Molecular Biology
• Pharmacology

Background:

• Hyperpolarization-activated cation channels generate the cardiac I(f) current, essential for sino-atrial node (SAN) pacemaking and heart rate.
• HCN4 is the primary isoform in the SAN, but other isoforms may contribute to cardiac function.
• Dysregulation of I(f) in conditions like heart failure may contribute to arrhythmogenesis.

Purpose of the Study:

• To review the role of I(f) in pacemaking and non-pacemaking cardiomyocytes.
• To analyze HCN channel mutants and their phenotypes.
• To discuss the therapeutic implications of I(f) inhibition in cardiac disorders.

Main Methods:

• Review of existing literature on HCN channel function and cardiac physiology.
• Analysis of data from various HCN4-targeting mouse mutants.
• Examination of clinical trial data for HCN channel blockers.

Main Results:

• Cardiac HCN mutants exhibit diverse and unexplained phenotypes, highlighting the complexity of I(f) function.
• I(f) upregulation in hypertrophic and failing hearts may promote arrhythmias.
• HCN channel blockers, such as ivabradine, show therapeutic promise beyond heart rate reduction.

Conclusions:

• Further research into cardiac HCN channels is vital for developing novel therapeutics.
• HCN channel blockers represent a promising class of drugs for treating cardiac conditions.
• The precise mechanisms of ivabradine's benefits in heart failure require elucidation.